SCHEMBL9257655

SCHEMBL9257655

CCCCCCCN(Cc1ccc(OCOCCOC)cc1)C(=O)Nc1ccc(OC)cc1OCC1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.42
HDAC1 Q13547 3/20 0.42
HDAC6 Q9UBN7 3/20 0.42
HDAC3 O15379 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
GAA P10253 2/20 0.41
HTT P42858 2/20 0.41
SOAT1 P35610 1/20 0.40
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A1 P00352 1/20 0.39
AGER Q15109 1/20 0.39
SLC2A1 P11166 1/20 0.38
CNR2 P34972 1/20 0.38
PPARA Q07869 3/20 0.37
PPARG P37231 1/20 0.37
PPARD Q03181 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9252619 0.90 HDAC1 (0.51) TSHRHDAC1HDAC6HDAC3HDAC2
SCHEMBL9261604 0.85 HDAC1 (0.51) TSHRHDAC1HDAC6HDAC3HDAC2
SCHEMBL9252884 0.84 HDAC1 (0.46) TSHRHDAC1HDAC6HDAC3HDAC2
SCHEMBL9251911 0.84 HDAC1 (0.53) TSHRHDAC1HDAC6HDAC3HDAC2
SCHEMBL8925832 0.83 PPARA (0.43) TSHRHDAC1HDAC6HDAC3HDAC2
SCHEMBL9253807 0.83 TSHR (0.54) TSHRHDAC1HDAC6HDAC3HDAC2
SCHEMBL9253022 0.82 PPARG (0.50) TSHRHDAC1HDAC6HDAC3HDAC2
SCHEMBL9577853 0.82 TSHR (0.56) TSHRHDAC1HDAC6HDAC3HDAC2
SCHEMBL9259129 0.81 HDAC1 (0.47) TSHRHDAC1HDAC6HDAC3HDAC2
SCHEMBL9257832 0.80 HDAC1 (0.44) TSHRHDAC1HDAC6HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5422373-A An alkoxybenzyl-alkylene-arylurea anticholesterol, antilipemic agents and enzyme inhibitors BURROUGHS WELLCOME CO. (US) 1995-06-06 US disclosed
EP-0550568-A1 ANTI-ATHEROSCLEROTIC ARYL COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1993-07-14 EP disclosed
WO-1992006075-A1 ANTI-ATHEROSCLEROTIC ARYL COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1992-04-16 WO disclosed